Mucolipidosis II is an inherited lysosomal storage disease, similar in presentation to the human disease of the same name. It is caused by a deficiency of N-acetylglucosamine-1-phosphotransferase (GNPTAB), which leads to compromised internalization of acid hydrolases into lysosomes, which hinders the proper catabolism of a variety of substances. The disease is characterized by severe progressive neuropathy and oculoskeletal dysfunction in humans.
GNPTAB
Autosomal recessive
Clinical signs of this disease include a deformed face and body and failure to thrive at birth. As they age, affected kittens will display an inability to grow normally and an overall lethargy compared to normal kittens. In the end stages of this disease, it is either fatal or kittens will need to be euthanized.
Because this disease is rare, there is no established diagnostic process. A presumptive diagnosis is made based off of clinical signs and can be confirmed via a genetic test.
Current data does not indicate that specific breeds are at a higher risk.
https://pubmed.ncbi.nlm.nih.gov/30591066/
Disease diagnosis and treatment should always be performed by a veterinarian. The following information is for educational purposes only.
Recommended by top vets with decades of experience
21 breeds
64 genetic health markers
50 genetic trait markers